Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
The Journal of Clinical Investigation
|
June 6, 2007
A beneficial role for IL-1 beta in Alzheimer disease?
Cynthia A Lemere
Molecular Neurodegeneration
|
October 24, 2013
Immunotherapy for Alzheimer's disease: hoops and hurdles
Cynthia A Lemere
Progress in Brain Research
|
August 8, 2009
Developing novel immunogens for a safe and effective Alzheimer's disease vaccine
Cynthia A Lemere
Nature Reviews. Neurology
|
February 9, 2010
Can Alzheimer disease be prevented by amyloid-beta immunotherapy?
Cynthia A Lemere, Eliezer Masliah
Acta Neuropathologica
|
April 29, 2025
CAA proteomics meta-analysis reveals novel targets, key players, and the effects of sex, APOE, and brain region in humans
Curran Varma, Cynthia A Lemere
Acta Neuropathologica Communications
|
July 31, 2020
Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models
Sathish Kumar, Cynthia A Lemere, Jochen Walter
Neuro-Degenerative Diseases
|
August 16, 2006
Developing novel immunogens for an effective, safe Alzheimer's disease vaccine
Marcel Maier, Timothy J Seabrook, Cynthia A Lemere
Vaccine
|
August 2, 2005
Modulation of the humoral and cellular immune response in Abeta immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G)
Marcel Maier, Timothy J Seabrook, Cynthia A Lemere
Journal of Neuroinflammation
|
December 21, 2007
Osteopetrotic (op/op) mice have reduced microglia, no Abeta deposition, and no changes in dopaminergic neurons
Yoichi Kondo, Cynthia A Lemere, Timothy J Seabrook
JAMA Neurology
|
July 6, 2021
APOE ε4 Association With Cognition and Alzheimer Disease Biomarkers in Down Syndrome-Implications for Clinical Trials and Treatments for All
Cynthia A Lemere, Elizabeth Head, David M Holtzman
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
The Journal of Clinical Investigation
|
June 6, 2007
A beneficial role for IL-1 beta in Alzheimer disease?
Cynthia A Lemere
Molecular Neurodegeneration
|
October 24, 2013
Immunotherapy for Alzheimer's disease: hoops and hurdles
Cynthia A Lemere
Progress in Brain Research
|
August 8, 2009
Developing novel immunogens for a safe and effective Alzheimer's disease vaccine
Cynthia A Lemere
Nature Reviews. Neurology
|
February 9, 2010
Can Alzheimer disease be prevented by amyloid-beta immunotherapy?
Cynthia A Lemere, Eliezer Masliah
Acta Neuropathologica
|
April 29, 2025
CAA proteomics meta-analysis reveals novel targets, key players, and the effects of sex, APOE, and brain region in humans
Curran Varma, Cynthia A Lemere
Acta Neuropathologica Communications
|
July 31, 2020
Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models
Sathish Kumar, Cynthia A Lemere, Jochen Walter
Neuro-Degenerative Diseases
|
August 16, 2006
Developing novel immunogens for an effective, safe Alzheimer's disease vaccine
Marcel Maier, Timothy J Seabrook, Cynthia A Lemere
Vaccine
|
August 2, 2005
Modulation of the humoral and cellular immune response in Abeta immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G)
Marcel Maier, Timothy J Seabrook, Cynthia A Lemere
Journal of Neuroinflammation
|
December 21, 2007
Osteopetrotic (op/op) mice have reduced microglia, no Abeta deposition, and no changes in dopaminergic neurons
Yoichi Kondo, Cynthia A Lemere, Timothy J Seabrook
JAMA Neurology
|
July 6, 2021
APOE ε4 Association With Cognition and Alzheimer Disease Biomarkers in Down Syndrome-Implications for Clinical Trials and Treatments for All
Cynthia A Lemere, Elizabeth Head, David M Holtzman
Page
of 11